Cephalexin for BV: What Patients Need to Know
The debate over cephalexin for BV hinges on two critical factors: efficacy and risk. Unlike metronidazole, which directly targets anaerobic pathogens...
Tag
The debate over cephalexin for BV hinges on two critical factors: efficacy and risk. Unlike metronidazole, which directly targets anaerobic pathogens...